Syngene International: USFDA Clearance Enhances Regulatory Standing

🧪

announced favorable outcomes from recent USFDA inspections. Its Semicon Park facility passed with zero observations, while the Biocon Park SEZ site received an EIR marked ‘Voluntary Action Indicated’, with CAPA plans accepted. These developments strengthen compliance and are not expected to impact operations or financials.